000 | 01445 a2200409 4500 | ||
---|---|---|---|
005 | 20250513232043.0 | ||
264 | 0 | _c20010322 | |
008 | 200103s 0 0 eng d | ||
022 | _a0160-2446 | ||
024 | 7 |
_a10.1097/00005344-200102000-00004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBasset, A | |
245 | 0 | 0 |
_aRenin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _cFeb 2001 |
||
300 |
_a163-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 |
_aHyperthyroidism _xcomplications |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
650 | 0 | 4 |
_aReceptors, Angiotensin _xphysiology |
650 | 0 | 4 |
_aRenin-Angiotensin System _xphysiology |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
650 | 0 | 4 |
_aValine _xanalogs & derivatives |
650 | 0 | 4 | _aValsartan |
700 | 1 | _aBlanc, J | |
700 | 1 | _aMessas, E | |
700 | 1 | _aHagège, A | |
700 | 1 | _aElghozi, J L | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 37 _gno. 2 _gp. 163-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-200102000-00004 _zAvailable from publisher's website |
999 |
_c11147910 _d11147910 |